BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21484373)

  • 1. Assessment of α7 nicotinic acetylcholine receptor availability in juvenile pig brain with [¹⁸F]NS10743.
    Deuther-Conrad W; Fischer S; Hiller A; Becker G; Cumming P; Xiong G; Funke U; Sabri O; Peters D; Brust P
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1541-9. PubMed ID: 21484373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET Imaging of nicotinic acetylcholine receptors in baboons with 18F-AZAN, a radioligand with improved brain kinetics.
    Kuwabara H; Wong DF; Gao Y; Valentine H; Holt DP; Ravert HT; Dannals RF; Horti AG
    J Nucl Med; 2012 Jan; 53(1):121-9. PubMed ID: 22173841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging of alpha7 nicotinic acetylcholine receptors: design and evaluation of the potent radioligand [18F]NS10743.
    Deuther-Conrad W; Fischer S; Hiller A; Nielsen EØ; Timmermann DB; Steinbach J; Sabri O; Peters D; Brust P
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):791-800. PubMed ID: 19137292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of high-affinity α4β2 nicotinic acetylcholine receptors in humans with 18F-AZAN, a radioligand with optimal brain kinetics.
    Wong DF; Kuwabara H; Kim J; Brasic JR; Chamroonrat W; Gao Y; Valentine H; Willis W; Mathur A; McCaul ME; Wand G; Gean EG; Dannals RF; Horti AG
    J Nucl Med; 2013 Aug; 54(8):1308-14. PubMed ID: 23801676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements.
    Ettrup A; Mikkelsen JD; Lehel S; Madsen J; Nielsen EØ; Palner M; Timmermann DB; Peters D; Knudsen GM
    J Nucl Med; 2011 Sep; 52(9):1449-56. PubMed ID: 21828113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-ASEM, a radiolabeled antagonist for imaging the α7-nicotinic acetylcholine receptor with PET.
    Horti AG; Gao Y; Kuwabara H; Wang Y; Abazyan S; Yasuda RP; Tran T; Xiao Y; Sahibzada N; Holt DP; Kellar KJ; Pletnikov MV; Pomper MG; Wong DF; Dannals RF
    J Nucl Med; 2014 Apr; 55(4):672-7. PubMed ID: 24556591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of α7 nicotinic acetylcholine receptors in brain and cerebral vasculature of juvenile pigs with [(18)F]NS14490.
    Rötering S; Deuther-Conrad W; Cumming P; Donat CK; Scheunemann M; Fischer S; Xiong G; Steinbach J; Peters D; Sabri O; Bucerius J; Brust P
    EJNMMI Res; 2014; 4():43. PubMed ID: 25136512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.
    Ravert HT; Dorff P; Foss CA; Mease RC; Fan H; Holmquist CR; Phillips E; McCarthy DJ; Heys JR; Holt DP; Wang Y; Endres CJ; Dannals RF; Pomper MG
    Nucl Med Biol; 2013 Aug; 40(6):731-9. PubMed ID: 23680470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of new radioligands [(11)C]A-833834 and [(11)C]A-752274 for positron-emission tomography of α7-nicotinic acetylcholine receptors.
    Horti AG; Ravert HT; Gao Y; Holt DP; Bunnelle WH; Schrimpf MR; Li T; Ji J; Valentine H; Scheffel U; Kuwabara H; Wong DF; Dannals RF
    Nucl Med Biol; 2013 Apr; 40(3):395-402. PubMed ID: 23294899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Derivatives of dibenzothiophene for positron emission tomography imaging of α7-nicotinic acetylcholine receptors.
    Gao Y; Kellar KJ; Yasuda RP; Tran T; Xiao Y; Dannals RF; Horti AG
    J Med Chem; 2013 Oct; 56(19):7574-89. PubMed ID: 24050653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging of α
    Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
    Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
    Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The distribution of the alpha7 nicotinic acetylcholine receptor in healthy aging: An in vivo positron emission tomography study with [
    Coughlin JM; Du Y; Rosenthal HB; Slania S; Min Koo S; Park A; Solomon G; Vranesic M; Antonsdottir I; Speck CL; Rootes-Murdy K; Lerner A; Rowe SP; Wang Y; Lesniak WG; Minn I; Bakker A; Smith GS; Dannals RF; Kuwabara H; Horti A; Wong DF; Pomper MG
    Neuroimage; 2018 Jan; 165():118-124. PubMed ID: 28993233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-human PET quantification study of cerebral α4β2* nicotinic acetylcholine receptors using the novel specific radioligand (-)-[(18)F]Flubatine.
    Sabri O; Becker GA; Meyer PM; Hesse S; Wilke S; Graef S; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Habermann B; Neuhaus P; Fischer S; Tiepolt S; Deuther-Conrad W; Barthel H; Schönknecht P; Brust P
    Neuroimage; 2015 Sep; 118():199-208. PubMed ID: 26037057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of [(18)F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography.
    Horti AG
    Biochem Pharmacol; 2015 Oct; 97(4):566-575. PubMed ID: 26232729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
    Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
    PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
    Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
    Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.
    Toyohara J; Ishiwata K; Sakata M; Wu J; Nishiyama S; Tsukada H; Hashimoto K
    PLoS One; 2010 Feb; 5(2):e8961. PubMed ID: 20126539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.
    Papke RL; Peng C; Kumar A; Stokes C
    Neurosci Lett; 2018 Jun; 677():6-13. PubMed ID: 29679680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.